NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma
Authors:
- 1 November 2010
- journal article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 23 (8) , 675-681
Abstract
Summary. NK cells can be divided into two subsets, CD56dim and CD56bright NK cells, based on their expression of CD56 and CD16. In the present study, we analyzKeywords
This publication has 25 references indexed in Scilit:
- Expression Pattern of Immune Suppressive Cytokines and Growth Factors in Oesophageal Adenocarcinoma Reveal a Tumour Immune Escape‐promoting MicroenvironmentScandinavian Journal of Immunology, 2008
- Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinomaBritish Journal of Cancer, 2008
- Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2Cancer Research, 2007
- Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinomaBritish Journal of Cancer, 2007
- TGFβ promotes conversion of CD16+peripheral blood NK cells into CD16−NK cells with similarities to decidual NK cellsProceedings of the National Academy of Sciences, 2007
- Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patientsClinical & Experimental Metastasis, 2007
- Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity against Esophageal Squamous Cell CarcinomaClinical Cancer Research, 2005
- Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual diseaseGut, 2005
- Preferential apoptosis of CD56dim natural killer cell subset in patients with cancerEuropean Journal of Immunology, 2002
- Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicityEuropean Journal of Immunology, 1996